Thank you for sharing!

Your article was successfully shared with the contacts you provided.
The Supreme Court declined Monday to hear an appeal from a drug manufacturer that sought to limit evidence that fen-phen users want to present in their lawsuits claiming heart valve damage. In a defeat for drug maker Wyeth, the court let stand a lower ruling that a federal judge went too far when he issued an order restricting the evidence. The Philadelphia judge reasoned that the diet drug users had violated a $3.75 billion settlement agreement with the Madison, N.J.-based company. In legal filings, Wyeth argued that former users of its Pondimin and Redux pills violated the agreement not to seek punitive damages when they chose to “opt out” of the federal class-action settlement to pursue their own lawsuits. The judge properly barred the plaintiffs from using evidence in state court such as those suggesting Wyeth placed marketing ahead of health and safety concerns, because the evidence might encourage juries to award punitive damages, the company argued. The 3rd U.S. Circuit Court of Appeals disagreed in ruling that the judge’s order improperly limited evidence that could help plaintiffs prove their injury. The federal judge’s action also didn’t properly consider the rights of state courts since the lawsuits were being heard there, the 3rd Circuit said. Wyeth pulled Pondimin and Redux, the fenfluramine half of fen-phen, from the market in September 1997 amid reports some users had heart valve damage and a few had a deadly lung condition. Fen-phen was never an FDA-approved combination, and the phentermine half is still sold. The Supreme Court’s action Monday means that plaintiffs will now be able to present evidence previously barred, but they still may not use those that are relevant only to a claim for punitive damages. The case is Wyeth v. Smart, 04-437. Copyright 2004 Associated Press. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.

Want to continue reading?
Become a Free ALM Digital Reader.

Benefits of a Digital Membership:

  • Free access to 3 articles* every 30 days
  • Access to the entire ALM network of websites
  • Unlimited access to the ALM suite of newsletters
  • Build custom alerts on any search topic of your choosing
  • Search by a wide range of topics

*May exclude premium content
Already have an account?


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2020 ALM Media Properties, LLC. All Rights Reserved.